Back to top
more

IDEXX Laboratories (IDXX)

(Real Time Quote from BATS)

$469.35 USD

469.35
443,535

-8.49 (-1.78%)

Updated Aug 2, 2024 03:04 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.03%
2Buy17.70%
3Hold9.37%
4Sell5.03%
5Strong Sell2.48%
S&P50011.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

4-Sell of 5       4  

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value A Growth C Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (101 out of 251)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Mazor Robotics Receives Order for Three Mazor X Systems

by Zacks Equity Research

Israel-based developer of robotic technology and products, Mazor Robotics Ltd. (MZOR), recently announced a three-system order for the Mazor X, from a leading mid-Atlantic health care organization.

    Cardinal Health to Pay $44M as Civil Penalty Settlement

    by Zacks Equity Research

    Cardinal Health Inc. (CAH) announced that it would shell out $44 million as civil penalties for a 2012 administrative settlement with the U.S. Drug Enforcement Agency or DEA.

      Varian to Acquire PerkinElmer's Medical Imaging Business

      by Zacks Equity Research

      Varian Medical Systems, Inc. (VAR) recently announced an agreement to takeover the Medical Imaging business of Waltham, MA-based PerkinElmer, Inc. (PKI) for $276 million.

        DaVita Ties Up With WellHealth, Expands in Southern Nevada

        by Zacks Equity Research

        DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners Nevada, a unit within its medical group, has acquired WellHealth Quality Care.

          Fluidigm Unveils High-Throughput Integrated Fluidic Circuit

          by Zacks Equity Research

          Fluidigm Corporation (FLDM), a leading player in the analysis of single cells and industrial application of genomics, recently unveiled a new high-throughput integrated fluidic circuit (HT IFC) to separate single cells during mRNA sequencing analysis.

            WebMD Health (WBMD) Repurchaces 2 Million Common Shares

            by Zacks Equity Research

            WebMD Health Corp. (WBMD) announced that it has completed a tender offer to purchase 2 million shares of its common stock.

              Accuray: Hong Kong Sanatorium to Buy 3 Radixact Systems

              by Zacks Equity Research

              Accuray Incorporated (ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital per which the latter would purchase three Radixact Systems.

                Meridian Bioscience Partners MedCaptain, Expands in China

                by Zacks Equity Research

                Meridian Bioscience, Inc. (VIVO) announced that its Magellan Diagnostics business has signed a distribution agreement with China-based MedCaptain Medical Technology.

                  DexCom (DXCM) Gains FDA Approval for G5 Mobile CGM System

                  by Zacks Equity Research

                  San Diego, CA-based DexCom, Inc. (DXCM), a renowned medical device company, announced the U.S. FDA approval for its G5 Mobile CGM (continuous glucose monitoring) system.

                    Luminex Awarded R&D 100 for ARIES Systems in November

                    by Zacks Equity Research

                    Luminex Corporation (LMNX) announced that its ARIES Systems was awarded the R&D 100 Award at the 54th Annual R&D 100 Awards ceremony in November.

                      Allscripts Buys Core Medical Solutions, Expands in Australia

                      by Zacks Equity Research

                      Allscripts Healthcare Solutions, Inc. (MDRX), a leading global provider of information technology and services to healthcare organizations, recently announced the acquisition of Core Medical Solutions to expand its offerings in Australia.

                        Envision Healthcare Ties Up with Alabama Neonatal Medicine

                        by Zacks Equity Research

                        Envision Healthcare Corporation (EVHC) announced the acquisition of Alabama Neonatal Medicine, P.C. and the extension of its Women's and Children's Services specialty.

                          Neogen (NEOG) to Buy Quat-Chem, Shares Hit 52-Week High

                          by Zacks Equity Research

                          Neogen Corporation (NEOG), recently announced the acquisition of United Kingdom-based Quat-Chem Ltd., a chemical company which develops, manufactures and sells agricultural, industrial, and food processing biocidal hygiene products.

                            Varian (VAR) in Just 100 List from JUST Capital and Forbes

                            by Zacks Equity Research

                            Varian Medical Systems Inc. (VAR) announced it was included in the inaugural JUST 100 List.

                              Veeva Systems Set to Grow on Subscription Revenue Focus

                              by Zacks Equity Research

                              On Nov 30, we issued an updated research report on Pleasanton, CA-based Veeva Systems Inc. (VEEV).

                                TrovaGene Inks Contract with Boreal Genomics, Stock Down

                                by Zacks Equity Research

                                TrovaGene Inc. (TROV), a molecular diagnostic company, recently announced the signing of a long-term Supply and Distribution Agreement with Boreal Genomics.

                                  Patterson Companies: Q2 Results Dismal, Forex a Concern

                                  by Zacks Equity Research

                                  On Nov 30, we issued an updated research report on St. Paul, MN-based Patterson Companies Inc. (PDCO) ??? a leading distributor of dental and animal health products.

                                    Evolent Health (EVH) Prices $110M Convertible Senior Notes

                                    by Zacks Equity Research

                                    Evolent Health, Inc. (EVH), announced the pricing of $110.0 million worth senior notes.

                                      Cynosure (CYNO) Gets CFDA Approval to Market Icon System

                                      by Zacks Equity Research

                                      Cynosure, Inc. (CYNO) announced that it has received clearance from the China Food and Drug Administration (CFDA) to market the Icon Aesthetic System.

                                        Baxter (BAX) Inks Partnership with Americares, Stock Down

                                        by Zacks Equity Research

                                        Baxter International Inc. (BAX) announced a new oral health project in collaboration with Americares, a health-focused relief and development organization.

                                          Varian & Komazawa Establish Radiotherapy Education Center

                                          by Zacks Equity Research

                                          Varian Medical Systems Inc. (VAR) announced a partnership with Komazawa University in Japan to establish an advanced radiotherapy education center equipped with a fully functional Varian TrueBeam medical linear accelerator.